Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 116 | 1 | 103 | −12 |
| Shares | 8.58M | 1.00K | 9.05M | +476.0K (+5.6%) |
| Value | $122.4M | $14.0K | $78.4M | −$44.0M (−36.0%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 385,413 | $3.33M | 0.01% |
| FMR LLC | 48,360 | $418.0K | 0.00% |
| Private Portfolio Partners LLC | 42,250 | $365.5K | 0.09% |
| Knoll Capital Management, LLC | 20,000 | $173.0K | 0.11% |
| ExodusPoint Capital Management, LP | 18,325 | $159.0K | 0.00% |
| Man Group plc | 15,600 | $135.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 13,000 | $112.0K | 0.00% |
| Amalgamated Bank | 6,457 | $56.0K | 0.00% |
| Amalgamated Financial Corp. | 6,457 | $56.0K | 0.00% |
| Ensign Peak Advisors, Inc | 1,760 | $15.0K | 0.00% |
| Cutler Group LP | 700 | $6.00K | 0.00% |
| Massmutual Trust Co FSB | 68 | $1.00K | 0.00% |
Sold out (24)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Renaissance Technologies LLC | 203,200 | $2.90M |
| HRT Financial LP | 64,198 | $916.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 50,786 | $725.0K |
| Alpine Global Management, LLC | 43,013 | $614.0K |
| Squarepoint Ops LLC | 39,433 | $563.0K |
| Old Mission Capital LLC | 38,691 | $553.0K |
| Boulder Hill Capital Management LP | 38,600 | $551.0K |
| Walleye Capital LLC | 36,740 | $525.0K |
| Ergoteles LLC | 33,800 | $483.0K |
| Janney Montgomery Scott LLC | 23,260 | $332.0K |
| Balyasny Asset Management LLC | 21,687 | $310.0K |
| Virtu Financial LLC | 21,191 | $303.0K |
| Susquehanna International Group Ltd. | 13,539 | $178.0K |
| Trexquant Investment LP | 12,088 | $173.0K |
| Parametric Portfolio Associates LLC | 11,764 | $168.0K |
| XTX Topco Ltd | 10,556 | $151.0K |
| SG Americas Securities, LLC | 8,631 | $123.0K |
| Dumont & Blake Investment Advisors LLC | 8,250 | $118.0K |
| Simplex Trading, LLC | 6,930 | $98.0K |
| Group One Trading, L.P. | 5,655 | $81.0K |
| Jefferies Group LLC | 1,585 | $22.6K |
| US Bancorp | 1,000 | $14.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 360 | $5.00K |
| Harvest Fund Management Co., Ltd | 344 | $4.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Carroll Financial Associates, Inc. | 1,000 | $14.0K |